Optical coherence tomography-verified morphological correlates of high-intensity coronary plaques on non-contrast T1-weighted magnetic resonance imaging in patients with stable coronary artery disease.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 08 06 2017
accepted: 14 02 2018
pubmed: 8 3 2018
medline: 5 6 2019
entrez: 8 3 2018
Statut: ppublish

Résumé

Coronary high-intensity plaques (HIPs) with a high plaque-to-myocardial signal intensity ratio (PMR) on non-contrast T1-weighted imaging in patients with stable coronary artery disease (CAD) are associated with future coronary events. To characterize the morphological substrate of HIP, we performed a correlative optical coherence tomography (OCT) study. We examined 137 lesions in 105 patients with stable angina pectoris or silent myocardial ischaemia scheduled for percutaneous coronary intervention (PCI) using a 3 T magnetic resonance scanner. Pre-interventional OCT was performed for PCI target lesions. HIP was defined as PMR ≥ 1.4. Of the 137 lesions, 34% were HIP and 66% were non-HIP. The prevalence of lipid-rich plaque (96% vs. 70%, P < 0.001), macrophage accumulation (65% vs. 46%, P = 0.046), cholesterol crystals (46% vs. 22%, P = 0.006), and healed plaque rupture (multiple layers of different optical densities overlaying a large lipid accumulation, 72% vs. 18%, P < 0.001) was significantly higher in the HIP group than the non-HIP group; no significant differences were observed for the presence of thin cap fibroatheroma, intracoronary thrombus, and plaque rupture between the two groups. Multivariable stepwise logistic regression analysis showed that HIP was significantly associated with the presence of healed plaque rupture [odds ratio (OR) 9.32; 95% confidence interval (95% CI) 4.05-22.71; P < 0.001] and lipid-rich plaque (OR 4.38; 95% CI 1.08-29.77; P = 0.038). The significant association between HIP- and OCT-derived healed plaque rupture and large lipid core provides new insights into the characteristics of high-risk plaques, even in clinically stable CAD.

Identifiants

pubmed: 29514171
pii: 4921316
doi: 10.1093/ehjci/jey035
pmc: PMC6302262
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-83

Références

JACC Cardiovasc Imaging. 2015 Oct;8(10):1143-52
pubmed: 26363839
Eur Heart J Cardiovasc Imaging. 2012 May;13(5):394-9
pubmed: 22277117
Circulation. 2011 Jul 26;124(4):416-24
pubmed: 21747055
JACC Cardiovasc Imaging. 2009 Jun;2(6):720-8
pubmed: 19520342
J Am Coll Cardiol. 2014 Mar 18;63(10):989-99
pubmed: 24345595
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Circulation. 2003 Jan 7;107(1):113-9
pubmed: 12515752
Circ J. 2013;77(8):1975-83
pubmed: 23877708
Nat Rev Cardiol. 2016 Feb;13(2):79-98
pubmed: 26503410
Am J Cardiol. 2006 Apr 15;97(8):1172-5
pubmed: 16616021
Eur Heart J. 2015 Aug 1;36(29):1913-22
pubmed: 26033978
Circulation. 2003 Jun 24;107(24):3047-52
pubmed: 12796133
Circulation. 2001 Oct 23;104(17):2051-6
pubmed: 11673345
Circulation. 1995 Sep 1;92(5):1355-74
pubmed: 7648691
Circulation. 2002 Sep 24;106(13):1640-5
pubmed: 12270856
J Am Coll Cardiol. 2015 Jul 21;66(3):245-256
pubmed: 26184618
Nat Rev Cardiol. 2014 Jul;11(7):379-89
pubmed: 24776706
Circulation. 2001 Feb 20;103(7):934-40
pubmed: 11181466
N Engl J Med. 2003 Dec 11;349(24):2316-25
pubmed: 14668457
Am J Cardiol. 2006 Jun 15;97(12):1713-7
pubmed: 16765119
Heart. 1999 Sep;82(3):265-8
pubmed: 10455072
Circ Cardiovasc Imaging. 2016 Aug;9(8):
pubmed: 27511975
JACC Cardiovasc Imaging. 2015 Jun;8(6):741-3
pubmed: 25457759
J Am Coll Cardiol. 2009 Jun 30;54(1):49-57
pubmed: 19555840
J Am Coll Cardiol. 2012 May 22;59(21):1881-8
pubmed: 22595407
Circ J. 2015;79(1):218-20
pubmed: 25342532
Am J Cardiol. 2010 Feb 1;105(3):318-22
pubmed: 20102942

Auteurs

Tomoaki Kanaya (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Fumiyuki Otsuka (F)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Yasuhide Asaumi (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Yu Kataoka (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Yoshiaki Morita (Y)

Department of Radiology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Hiroyuki Miura (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Kazuhiro Nakao (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Masashi Fujino (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Tomohiro Kawasaki (T)

Cardiovascular Center, Shin-Koga Hospital, Kurume, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Teruo Inoue (T)

Department of Cardiovascular Medicine, Dokkyo Medical University Hospital, 880 kitakobayashi, Mibu, Tochigi, Japan.

Jagat Narula (J)

Icahn School of Medicine at Mount Sinai, 1190 Fifth Avenue New York, NY, USA.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH